HomeHealthcare & Life SciencesPharmaceuticals Bioidentical Hormones Market

United Kingdom Bioidentical Hormones Market Size & Outlook, 2025-2033


United Kingdom Bioidentical Hormones Market Insights

  • According to Reed Intelligence analysis, the United Kingdom Bioidentical Hormones Market size was USD 208.14 Million in 2024 and is projected to reach USD 358.8 Million by 2033.
  • The United Kingdom market is projected to grow at a CAGR of 6.2% between 2026 and 2033.
  • By segment, Estrogens emerged as the largest By Type in terms of market size in 2024.
  • Estrogens is anticipated to remain the most attractive By Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • As of 2024, United Kingdom held 5.78% of the global Bioidentical Hormones Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Bioidentical Hormones Market.
  • In Europe, Germany is expected to lead the regional Bioidentical Hormones Market size by 2033.
  • United Kingdom will remain the fastest-growing market in Europe, reaching USD 357.68 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 208.14 Million
Market Size In 2033 USD 358.8 Million
Largest segment Estrogens
Units Revenue in USD Million
CAGR 6.2% (2025-2033)
Segmnetation Covered
By Type
  1. Estrogens
  2. Progesterone
  3. Testosterone
  4. Others
By Form
  1. Tablets and capsules
  2. Creams and gels
  3. Injectables
  4. Patches and implants
  5. Others
By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
By End-use
  1. Hospitals
  2. Gynecology clinics
  3. Research laboratories
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports